P. Dostert

4.0k total citations
121 papers, 3.2k citations indexed

About

P. Dostert is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, P. Dostert has authored 121 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Cellular and Molecular Neuroscience, 35 papers in Molecular Biology and 23 papers in Organic Chemistry. Recurrent topics in P. Dostert's work include Neuroscience and Neuropharmacology Research (33 papers), Neurotransmitter Receptor Influence on Behavior (26 papers) and Parkinson's Disease Mechanisms and Treatments (20 papers). P. Dostert is often cited by papers focused on Neuroscience and Neuropharmacology Research (33 papers), Neurotransmitter Receptor Influence on Behavior (26 papers) and Parkinson's Disease Mechanisms and Treatments (20 papers). P. Dostert collaborates with scholars based in Italy, Japan and France. P. Dostert's co-authors include M. Strolin Benedetti, Makoto Naoi, Wakako Maruyama, W. Maruyama, Tsutomu Takahashi, Keith F. Tipton, Yulin Deng, Italo Poggesi, G Dordain and Kazuo Matsubara and has published in prestigious journals such as Analytical Chemistry, Annals of Neurology and Brain Research.

In The Last Decade

P. Dostert

118 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Dostert Italy 34 1.3k 996 972 486 339 121 3.2k
Neal Castagnoli United States 28 1.0k 0.8× 909 0.9× 1.1k 1.1× 349 0.7× 240 0.7× 74 3.4k
K. Magyar Hungary 30 944 0.7× 1.1k 1.1× 666 0.7× 566 1.2× 549 1.6× 192 3.3k
M. Strolin Benedetti Italy 37 1.1k 0.8× 1.1k 1.1× 588 0.6× 733 1.5× 599 1.8× 192 4.6k
Neal Castagnoli United States 35 1.4k 1.0× 1.3k 1.3× 1.3k 1.4× 531 1.1× 401 1.2× 152 4.7k
Michael A. Collins United States 33 1.4k 1.1× 1.4k 1.4× 757 0.8× 399 0.8× 439 1.3× 111 3.8k
Alan A. Boulton Canada 31 1.6k 1.2× 1.2k 1.2× 341 0.4× 333 0.7× 314 0.9× 147 3.4k
Anthony J. Trevor United States 34 2.2k 1.6× 1.4k 1.4× 1.6k 1.7× 1.3k 2.7× 657 1.9× 97 6.1k
J. P. M. Finberg Israel 36 1.5k 1.1× 1.1k 1.1× 1.5k 1.5× 891 1.8× 682 2.0× 116 4.6k
G. Zürcher Switzerland 27 553 0.4× 888 0.9× 608 0.6× 261 0.5× 318 0.9× 42 3.0k
P. C. Waldmeier Switzerland 40 2.8k 2.1× 2.3k 2.3× 890 0.9× 562 1.2× 556 1.6× 155 5.2k

Countries citing papers authored by P. Dostert

Since Specialization
Citations

This map shows the geographic impact of P. Dostert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Dostert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Dostert more than expected).

Fields of papers citing papers by P. Dostert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Dostert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Dostert. The network helps show where P. Dostert may publish in the future.

Co-authorship network of co-authors of P. Dostert

This figure shows the co-authorship network connecting the top 25 collaborators of P. Dostert. A scholar is included among the top collaborators of P. Dostert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Dostert. P. Dostert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Montestruc, François, et al.. (2008). Biodisponibilité absolue du midazolam après administration sous-cutanée à des volontaires sains. Médecine Palliative. 2(4). 189–195. 1 indexed citations
4.
Astruc, B, et al.. (2005). Steady‐state pharmacokinetics and pharmacodynamics of CHF3381, a novel antineuropathic pain agent, in healthy subjects. British Journal of Clinical Pharmacology. 59(4). 405–414. 3 indexed citations
5.
Montestruc, François, et al.. (2002). Absolute bioavailability of midazolam after subcutaneous administration to healthy volunteers. British Journal of Clinical Pharmacology. 54(4). 357–362. 35 indexed citations
6.
Sousa, Georges de, et al.. (1999). Comparative effects of rifabutin and rifampicin on cytochromes P450 and UDP-glucuronosyl-transferases expression in fresh and cryopreserved human hepatocytes. Chemico-Biological Interactions. 121(1). 37–48. 53 indexed citations
7.
Naoi, Makoto, W. Maruyama, Shinji Ohta, et al.. (1998). Effects of various tetrahydroisoquinoline derivatives on mitochondrial respiration and the electron transfer complexes. Journal of Neural Transmission. 105(6-7). 677–688. 39 indexed citations
10.
Takahashi, Tsutomu, W. Maruyama, Yulin Deng, et al.. (1997). Cytotoxicity of endogenous isoquinolines to human dopaminergic neuroblastoma SH-SY5Y cells. Journal of Neural Transmission. 104(1). 59–66. 36 indexed citations
11.
Fialip, J., et al.. (1996). Study of the antinociceptive effect of tetrahydropapaveroline derivatives. Interaction with opioids. Life Sciences. 59(11). PL133–PL139. 2 indexed citations
12.
Maruyama, Wakako, Takashi Abe, Hideo Tohgi, P. Dostert, & Makoto Naoi. (1996). A dopaminergic neurotoxin, (R)‐N‐methylsalsolinol, increases in parkinsonian cerebrospinal fluid. Annals of Neurology. 40(1). 119–122. 78 indexed citations
13.
Deng, Yulin, Wakako Maruyama, P. Dostert, et al.. (1995). Determination of the (R)- and (S)-enantiomers of salsolinol and N-methylsalsolinol by use of a chiral high-performance liquid chromatographic column. Journal of Chromatography B Biomedical Sciences and Applications. 670(1). 47–54. 48 indexed citations
14.
Naoi, Makoto, W. Maruyama, Yi‐Mo Deng, et al.. (1994). Inhibition of type a monoamine oxidase by 2(N)-methyl-6,7-dihydroxyisoquinolinium ions. Neurochemistry International. 25(5). 475–481. 13 indexed citations
15.
Maruyama, W., Daiichiro Nakahara, P. Dostert, Akihisa Takahashi, & Makoto Naoi. (1993). Naturally-occurring isoquinolines perturb monoamine metabolism in the brain: studied by in vivo microdialysis. Journal of Neural Transmission. 94(2). 91–102. 21 indexed citations
16.
Benedetti, M. Strolin, et al.. (1991). Is the oxidation of milacemide by monoamine oxidase a major factor in its anticonvulsant actions?. Biochemical Pharmacology. 41(11). 1731–1737. 23 indexed citations
17.
Benedetti, M. Strolin, P. Dostert, Domenico Barone, et al.. (1990). In vivo interaction of cabergoline with rat brain dopamine receptors labelled with [3H]N-n-propylnorapomorphine. European Journal of Pharmacology. 187(3). 399–408. 53 indexed citations
18.
Benedetti, M. Strolin, et al.. (1989). Ratio of the R and S enantiomers of salsolinol in food and human urine. Journal of Neural Transmission. 77(1). 47–53. 56 indexed citations
20.
Dostert, P., et al.. (1984). Mécanismes d'action et toxicologie biochimique de l'acide valproïque.. 10(4). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026